- Preoperative Selective Desensitization of Live Donor Liver Transplant Recipients Considering the Degree of T Lymphocyte Cross-Match Titer, Model for End-Stage Liver Disease Score, and Graft Liver Volume
-
Hong G, Yi NJ, Suh SW, Yoo T, Kim H, Park MS, Choi Y, Lee K, Lee KW, Park MH, Suh KS
- KMID: 1786103
- J Korean Med Sci.
- 2014 May;29(5):640-647.
- doi: 10.3346/jkms.2014.29.5.640
Several studies have suggested that a positive lymphocyte cross-matching (XM) is associated with low graft survival rates and a high prevalence of acute rejection after adult living donor liver transplantations... -
- CITED
-
- Close
- SHARE
-
- Close
- Use of Bortezomib as Anti-Humoral Therapy in Kidney Transplantation
-
Yang KS, Jeon H, Park Y, Jo IH, Kim JI, Moon IS, Choi BS, Park CW, Yang CW, Kim YS, Chung BH
- KMID: 1786104
- J Korean Med Sci.
- 2014 May;29(5):648-651.
- doi: 10.3346/jkms.2014.29.5.648
This study aimed to investigate the effect of bortezomib in the desensitization and treatment of acute antibody mediated rejection (AAMR) in kidney transplantation. Nine patients who received bortezomib therapy for... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of Severe Atopic Dermatitis with a Combination of Subcutaneous Allergen Immunotherapy and Cyclosporin
-
Nahm DH, Kim ME
- KMID: 1779701
- Yonsei Med J.
- 2012 Jan;53(1):158-163.
- doi: 10.3349/ymj.2012.53.1.158
PURPOSE: The clinical efficacy of subcutaneous allergen immunotherapy (SCIT) for the treatment of patients with severe atopic dermatitis (AD) using house dust mite (HDM) extract has been reported. Cyclosporin has... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Efficacy of Subcutaneous Allergen Immunotherapy in Patients with Atopic Dermatitis
-
Nahm DH, Kim ME, Kwon B, Cho SM, Ahn A
- KMID: 2427160
- Yonsei Med J.
- 2016 Nov;57(6):1420-1426.
- doi: 10.3349/ymj.2016.57.6.1420
PURPOSE: The clinical usefulness of subcutaneous allergen immunotherapy (SCIT) in the treatment of atopic dermatitis (AD) is still controversial. We analyzed the clinical efficacy of SCIT in patients with AD... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety of Accelerated Schedules of Subcutaneous Allergen Immunotherapy with House Dust Mite Extract in Patients with Atopic Dermatitis
-
Kim ME, Kim JE, Sung JM, Lee JW, Choi GS, Nahm DH
- KMID: 1779388
- J Korean Med Sci.
- 2011 Sep;26(9):1159-1164.
- doi: 10.3346/jkms.2011.26.9.1159
The safety of accelerated schedules of allergen immunotherapy (ASAI) in patients with bronchial asthma (BA) has been reported but there are little data on the safety of ASAI for patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Retrospective Analysis on the Effects of House Dust Mite Specific Immunotherapy for More Than 3 Years in Atopic Dermatitis
-
Lee J, Lee H, Noh S, Bae BG, Shin JU, Park CO, Lee KH
- KMID: 2374045
- Yonsei Med J.
- 2016 Mar;57(2):393-398.
- doi: 10.3349/ymj.2016.57.2.393
PURPOSE: In extrinsic atopic dermatitis (AD), house dust mites (HDM) play a role in eliciting or aggravating allergic lesions. The nature of skin inflammation in AD has raised a growing... -
- CITED
-
- Close
- SHARE
-
- Close
- Different Responses in Induction of Allergen Specific Immunoglobulin G4 and IgE-Blocking Factors for Three Mite Subcutaneous Immunotherapy Products
-
Park KH, Lee SC, Son YW, Jeong KY, Shin YS, Shin JU, Sim DW, Park HJ, Lee JH, Lee KH, Park JW
- KMID: 2427161
- Yonsei Med J.
- 2016 Nov;57(6):1427-1434.
- doi: 10.3349/ymj.2016.57.6.1427
PURPOSE: Specific immunoglobulin G4 (sIgG4) and immunoglobulin E (IgE)-blocking factors produced by subcutaneous immunotherapy (SCIT) play a critical role in the induction of allergen tolerance. However, comparative studies of available... -
- CITED
-
- Close
- SHARE
-
- Close
